iBio, Inc. (NYSEMKT:IBIO)
CAPS Rating:
A bio-pharmaceutical company focused on the development and commercialization of novel plant-made products for the prevention and treatment of serious infectious diseases.
A bio-pharmaceutical company focused on the development and commercialization of novel plant-made products for the prevention and treatment of serious infectious diseases.
Recs
New 1 star.